Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Huoxin pill for heart remodeling after PCI
ChiCTR2300076402Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital of Henan University of Chinese Medicine
- Start
- Jan 2023
- Countries
- 1
01
Overview
Phase 4 trial of Huoxin Pill in heart failure (HF) and coronary arteriosclerosis (2 arms), sponsored by First Affiliated Hospital of Henan University of Chinese Medicine. Primary endpoint: New York Heart Association functional class. Planned start Jan 2023; status: not yet recruiting.
02
Drugs
Huoxin Pill
03
Conditions
heart failure (HF)coronary arteriosclerosis
Beyond the preview
Go deeper on ChiCTR2300076402.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300076402.